QbD Update: More Science-Based Submissions but Also More Questions and Confusion
This article was originally published in The Gold Sheet
Executive Summary
Industry and regulators agree that they are still in the learning mode when it comes to implementing the quality-by-design paradigm for developing and producing pharmaceuticals.